Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP1A2 | P05177 | 1/20 | 0.61 |
| ▸ | TBXAS1 | P24557 | 2/20 | 0.60 |
| ▸ | HPGD | P15428 | 1/20 | 0.59 |
| ▸ | CYP3A4 | P08684 | 2/20 | 0.58 |
| ▸ | TSHR | P16473 | 1/20 | 0.58 |
| ▸ | ALPI | P09923 | 1/20 | 0.57 |
| ▸ | PKM | P14618 | 1/20 | 0.57 |
| ▸ | PTGS1 | P23219 | 1/20 | 0.57 |
| ▸ | XIAP | P98170 | 1/20 | 0.57 |
| ▸ | SLC7A5 | Q01650 | 1/20 | 0.57 |
| ▸ | NPC1 | O15118 | 2/20 | 0.57 |
| ▸ | RAB9A | P51151 | 2/20 | 0.57 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.56 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.54 |
| ▸ | CPA1 | P15085 | 2/20 | 0.53 |
| ▸ | CPA3 | P15088 | 2/20 | 0.53 |
| ▸ | FOLH1 | Q04609 | 1/20 | 0.53 |
| ▸ | CPB1 | P15086 | 1/20 | 0.53 |
| ▸ | CPB2 | Q96IY4 | 1/20 | 0.53 |
| ▸ | MEN1 | O00255 | 1/20 | 0.53 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL265577 | 1.00 | CYP1A2 (0.61) | CYP1A2TBXAS1HPGDCYP3A4TSHR | |
| SCHEMBL265135 | 1.00 | CYP1A2 (0.61) | CYP1A2TBXAS1HPGDCYP3A4TSHR | |
| SCHEMBL27514358 | 0.98 | CYP1A2 (0.59) | CYP1A2TBXAS1HPGDCYP3A4TSHR | |
| Water SCHEMBL10936876 | 0.98 | CYP1A2 (0.59) | CYP1A2TBXAS1HPGDCYP3A4TSHR | |
| SCHEMBL11237591 | 0.91 | TBXAS1 (0.59) | CYP1A2TBXAS1HPGDCYP3A4TSHR | |
| Tert-Butylamine SCHEMBL1883188 | 0.90 | ALPI (0.53) | CYP1A2TBXAS1HPGDCYP3A4TSHR | |
| Tert-Butylamine SCHEMBL1880992 | 0.90 | ALPI (0.53) | CYP1A2TBXAS1HPGDCYP3A4TSHR | |
| Tert-Butylamine SCHEMBL1880991 | 0.90 | ALPI (0.53) | CYP1A2TBXAS1HPGDCYP3A4TSHR | |
| SCHEMBL7507834 | 0.88 | MME (0.63) | CPA1 | |
| SCHEMBL16948243 | 0.88 | MME (0.63) | CPA1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1774 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4661890-A1 | PTP1B/TC-PTP DUAL INHIBITORS AND PROTEIN DEGRADERS | Purdue Research Foundation (US) | 2025-12-17 | — | — | EP | claimed |
| CN-119867364-A | Electronic atomized liquid with fruit fragrance | 思摩尔国际控股有限公司 | 2025-04-25 | — | — | CN | claimed |
| WO-2024167565-A1 | PTP1B/TC-PTP DUAL INHIBITORS AND PROTEIN DEGRADERS | PURDUE RESEARCH FOUNDATION (US) | 2024-08-15 | — | — | WO | claimed |
| US-20230348354-A1 | POLYARYL CARBOXYLIC FULLERENE DERIVATIVE AND USE THEREOF IN ANTI-CORONAVIRUS INFECTION | XIAMEN UNIVERSITY (CN) | 2023-11-02 | — | — | US | claimed |
| CN-114075105-B | Fullerene aryl polycarboxylic acid derivative and application thereof in resisting coronavirus infection | 厦门大学 | 2023-01-10 | — | — | CN | claimed |
| CN-113979854-B | Method for electrochemically preparing 2-phenylpropionic acid | 重庆沃肯精细化工有限公司 | 2022-06-28 | — | — | CN | claimed |
| CN-114075105-A | Fullerene aryl polycarboxylic acid derivative and application thereof in resisting coronavirus infection | 厦门大学 | 2022-02-22 | — | — | CN | claimed |
| CN-113979854-A | Method for electrochemically preparing 2-phenylpropionic acid | 重庆沃肯精细化工有限公司 | 2022-01-28 | — | — | CN | claimed |
| EP-3387099-B1 | FOOD CONTACT SURFACE SANITIZING LIQUID | CLOROX CO (US) | 2021-07-21 | — | — | EP | claimed |
| EP-3830233-A1 | STABILIZED COMPOSITIONS COMPRISING LEUCO COMPOUNDS | Milliken & Company (US) | 2021-06-09 | — | — | EP | claimed |
| WO-1998004290-A2 | COMPOSITIONS COMPRISING AN INDUCING AGENT AND AN ANTI-VIRAL AGENT FOR THE TREATMENT OF BLOOD, VIRAL AND CELLULAR DISORDERS | PERRINE SUSAN P (US) | 1998-02-05 | — | — | WO | claimed |
| WO-1996027369-A9 | COMPOSITIONS FOR THE TREATMENT OF BLOOD DISORDERS | — | 1996-12-27 | — | — | WO | claimed |
| WO-1996027369-A2 | COMPOSITIONS FOR THE TREATMENT OF BLOOD DISORDERS | THE TRUSTEES OF BOSTON UNIVERSITY (US) | 1996-09-12 | — | — | WO | claimed |
| US-5539054-A | THERMOPLASTIC RESIN AND N-VINYL LACTAM COPOLYMERS WITH TENSILE AND IMPACT STRENGTH | ROHM AND HAAS COMPANY (US) | 1996-07-23 | — | — | US | claimed |
| EP-0611077-A2 | Polyurethane elastomer blends | ROHM AND HAAS COMPANY (US) | 1994-08-17 | — | — | EP | claimed |
| US-5321110-A | Thickeners for shampoo, hair conditioners | ISP INVESTMENTS INC. (US) | 1994-06-14 | — | — | US | claimed |
| WO-1993025595-A1 | CATIONIC POLYMER COMPOSITIONS | ISP INVESTMENTS INC. (US) | 1993-12-23 | — | — | WO | claimed |
| EP-0339276-B1 | BATHING PREPARATION | Kao Corporation (JP) | 1992-06-03 | — | — | EP | claimed |
| US-5045617-A | Zwitterion terpolymers of a vinyl lactam, an amino alkyl acrylamide or acrylate, and a polymerizable carboxylic acid | ISP INVESTMENTS INC. (US) | 1991-09-03 | — | — | US | claimed |
| US-4999450-A | Alkylation, dehydrogenation, carbonylation, catalysis | NIPPON PETROCHEMICALS COMPANY, LIMITED (JP) | 1991-03-12 | — | — | US | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230348354-A1 | POLYARYL CARBOXYLIC FULLERENE DERIVATIVE AND USE THEREOF IN ANTI-CORONAVIRUS INFECTION | SARS1, CRHR1, ACE2 | CYP1A2 686/4885TBXAS1 4846/4885HPGD 3345/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.